Lucy Cureton

基本信息

Career Trajectory

Bio

Clinical Trial Manager for the GRASP (Getting it Right: Addressing Shoulder Pain) trial. I am the main point of contact for all queries concerning the GRASP study - please feel free to get in touch about the study!

I joined NDORMS in October 2016 as a Clinical Trial Manager. Prior to joining NDORMS, I worked as a Study Administrator on a number of large clinical trials for the Clinical Trials Service Unit (now part of the Nuffield Department of Population Health), which I joined in 2007.

Research Interests

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Health Outcomes 3 Months and 6 Months after Molnupiravir Treatment for COVID-19 for People at Higher Risk in the Community (PANORAMIC): a Randomised Controlled Trial

Victoria Harris,Jane Holmes, Oghenekome Gbinigie-Thompson,Najib M. Rahman,Duncan B. Richards,Gail Hayward,Jienchi Dorward,David M. Lowe,Joseph F. Standing,Judith Breuer,Saye Khoo,Stavros Petrou,Kerenza Hood,Haroon Ahmed,Andrew Carson-Stevens,Jonathan S. Nguyen-Van-Tam,Mahendra G. Patel,Benjamin R. Saville,Nick Francis,Nicholas P. B. Thomas, Philip Evans,Melissa Dobson,May Ee Png,Mark Lown, Oliver van Hecke,Bhautesh D. Jani,Nigel D. Hart, Daniel Butler,Lucy Cureton, Meena Patil,Monique Andersson,Maria Coates,Clare Bateman,Jennifer C. Davies,Ivy Raymundo-Wood, Andrew Ustianowski, Ly-Mee Yu, F. D. Richard Hobbs, Paul Little,Christopher C. Butler

LANCET INFECTIOUS DISEASESno. 1 (2025): 68-79

Cited0Views0WOSBibtex

Molnupiravir Treatment for COVID-19 in People at Higher Risk in the Community: Outcomes from the PANORAMIC Randomised Controlled Trial at Three and Six Months

crossref（2024）

Cited0Views0Bibtex

Platform Adaptive Trial of Novel Antivirals for Early Treatment of COVID-19 in the Community (PANORAMIC): Protocol for a Randomised, Controlled, Open-Label, Adaptive Platform Trial of Community Novel Antiviral Treatment of COVID-19 in People at Increased Risk of More Severe Disease

BMJ OPEN（2023）

Cited11Views0WOSBibtex

Molnupiravir Plus Usual Care Versus Usual Care Alone As Early Treatment for Adults with COVID-19 at Increased Risk of Adverse Outcomes (PANORAMIC): an Open-Label, Platform-Adaptive Randomised Controlled Trial

Christopher C. Butler,F. D. Richard Hobbs,Oghenekome A. Gbinigie,Najib M. Rahman,Gail Hayward,Duncan B. Richards,Jienchi Dorward,David M. Lowe,Joseph F. Standing,Judith Breuer,Saye Khoo,Stavros Petrou,Kerenza Hood,Jonathan S. Nguyen-Van-Tam,Mahendra G. Patel,Benjamin R. Saville,Joe Marion,Emma Ogburn,Julie Allen,Heather Rutter,Nick Francis,Nicholas P. B. Thomas,Philip Evans,Melissa Dobson,Tracie-Ann Madden,Jane Holmes,Victoria Harris,May Ee Png,Mark Lown,Oliver van Hecke,Michelle A. Detry,Christina T. Saunders,Mark Fitzgerald,Nicholas S. Berry,Lazaro Mwandigha,Ushma Galal,Sam Mort,Bhautesh D. Jani,Nigel D. Hart,Haroon Ahmed,Daniel Butler, Micheal McKenna,Jem Chalk,Layla Lavallee,Elizabeth Hadley,Lucy Cureton, Magdalena Benysek,Monique Andersson,Maria Coates,Sarah Barrett,Clare Bateman,Jennifer C. Davies,Ivy Raymundo-Wood,Andrew Ustianowski,Andrew Carson-Stevens,Ly-Mee Yu,Paul Little

LANCET（2023）

Cited223Views0WOSBibtex

223

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

其他

Papers共 17 篇Author StatisticsCo-AuthorSimilar Experts